DCR-MYC

· Dicerna Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DCR-MYC, covering 2018-09-04 to 2024-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1]

See pricing